ARNA, VHGI, EVDR, TWHI & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

With only a couple of sessions remaining before ARNA’s FDA date, we are watching this stock as closely as ever. We expect to see a significant amount of volatility from the stock this week, as we keep our eyes peeled for new press.

No matter how this all shakes out, we will want to keep ARNA on a short leash heading into the FDA date, as there are no guarantees to its performance, FDA approval or not. As we stated on Friday, smart traders may have already taken some profits off of the table.

VHGI Holdings, Inc.  VHGI

We first mentioned VHGI on December 9th, and on that day, we saw a great run totaling nearly 100% from .21-.40. By January the 23rd, that high increased nearly two-fold again, running up to .746.

On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce. All in all, we feel the recent selloff as a new opportunity with this stock.

Evader, Inc. EVDR

We first alerted EVDR on May 2nd. On May 3rd, it hit a high of .003, yielding us a rapid 150% overnight gain!

We have witnessed EVDR’s ability to make significant leaps in just a short time period, and will thus be monitoring closely for the next wave of activity.

Thwapr, Inc. THWI

Although THWI didnt put up the performance we hoped for last week, it did hold support at .026

We noticed some newsletter coverage over the weekend from various emailers, and look forward to seeing the actvity resulting from heightened awareness.


Extended Watchlist:


Incoming search terms:

  • potatoesz5w
  • properly542

THWI, ENTB & Today’s Extended Watchlist

Thwapr, Inc. THWI

THWI dipped as low as .0315 on Thursday, and bounced back to close at .0364. That adds up to a 16% intraday gain.

The stock held above its 20DMA. This week’s consolidation pattern does not threaten our opinions of THWI, as the price movement has been on relatively light volume. Once we see a pickup in volume, we should see some positive moves. We think this could happen as soon as next week.

Barchart is currently giving THWI a “Buy” Rating


Entest BioMedical Inc. ENTB

ENTB has been on one heck of a run of late. We are expecting such a play to show some consolidation after making such big moves (almost 1400% in the past month), and will be observing for this to occur.

Generally, a stock that has displayed these kinds of gains over a relatively short period are in for a bit of a slide; something that is generally followed up by a bounce. That is what we will be awaiting.


Extended Watchlist:


IBIO, ARNA, & Today’s Extended Watchlist

iBio, Inc. IBIO

We’ve been quietly watching IBIO for quite some time. This AMEX stock has been on a consistant downtrend for the past couple of months, and is reaching the point where we felt it was time to begin sniffing for a bottom.

As you can see from the chart below, IBIO has the look of a stock that could be in for quite a recovering run once that ultimate bottom is reached. Shares from this price level could really turn out to be a bargain in the long run.


Arena Pharmaceuticals, Inc. ARNA

ARNA hit a high of 8.65 on Wednesday.  That’s a 57% gain from the stock’s low (5.50) following our initial alert. It appears that many investors are, like us, highly anticpating the possibility of ARNA’s FDA Approval.

We’ve already seen sizable gains from ARNA, and certainly would like to keep the stock on our radars for the forseeable future. We will, of course, keep you updated as to the situation.


We’d like to congratulate any traders who managed to trade RGIN successfully yesterday, as it was not for the faint of heart. The stock opened at .285 yesterday, and hit a high of .44 before falling into the close at .20. Savvy traders could still have made an intraday gain of 54% early on, and if anyone caught the afternoon bounce from .151 to .249 that came following the high of day, an additional 62% gain was possible.


Extended Watchlist:

THWI, OMVE & Today’s Extended Watchlist

Thwapr, Inc. THWI

Within the past month, THWI has exploded 1336% from .0055 to .079. The stock ran into resistance at the 200DMA. After such a surge, consolidation, which we’ve been seeing over the past couple of weeks, is to be expected.

THWI has been maintaining support above the 20DMA, and has made higher lows for the past five sessions. To us, that seems like a recipe for another possible breakout.

Apart from a nice chart setup, the company has had a slew of PR’s over the past few weeks that we’ve linked to below. We’ve also included a video chart for your convenience.

Recent Press:

Thwapr Executes on Channel Partner Strategy in Asia -06/11

Thwapr to Localize Its iPhone App for China -06/04

Thwapr Takes Steps to Protect Its Patent-Pending Technology in China -05/31

Thwapr, Inc. Provides Corporate Update on Asia Progress and Asian Outlook -05/29


Omni Ventures, Inc. OMVE

Having seen higher lows for four consecutive sessions following a bounce off of its bottom, OMVE is another play that we dug up in our search for new blood.

Our penny-sense is starting to tingle, as all the chart indicators seem to be ripening up. We’ve generally observed, that once a stock moves past its 200DMA, a breakout often follows. That said, we’re looking at .22 (200DMA) as the next key area of resistance.

We’ve provided you with a video chart for OMVE as well:


We also wanted to congratulate anyone who was able to take advantage of our calls from yesterday’s report. Both YIPI and ARNA enjoyed solid performances during yesterday’s trading. Both stocks closed near their high-of-day on abnormally high volume.


Extended Watchlist:


VPER, RARS & Today’s Extended Watchlist

VPER has been on our radars for quite some time, with our first alert coming on March 13th. Since that time, there’s been the opportunity to trade this stock for a handsome profit on 4-5 separate occasions.

Following the last run from .0016 to .0055, we’ve undegone a consoldidation, holding support in the low .002′s. Should the stock break past resistance at .0026, .0029, and .0031 (the 20, 100, & 50DMA ‘s respectively), there seems a strong chance that this play could return to .004′s and higher, and we certainly dont frown upon gains on the order of 50%

We have prepared a video chart for your convenience, which can be found below:



Rarus Technologies Inc. RARS

We have been silently monitoring RARS for weeks, although it has not yet appeared in our newsletter coverage. After witnessing last week’s activity, we felt compelled to share it with you today.

On Monday, the stock was trading as low as .071. By the time Wednesday rolled around, the high had touched .144, for a gain of 103%

That jump pushed the stock above its 20DMA, and providing it can hold at that level or above, we believe that the recovery off of its bottom could continue.

Rarus Technologies Inc. Announces Its Zngle Platform Will Create Revenues By Competing In a $39.5 Billion Market Through Development of Self-Serve Ad Platform PR Newswire – Mon 8:00AM


Extended Watchlist: